Disseminated and circulating tumor cells in gastrointestinal oncology

Critical Reviews in Oncology/Hematology

Volumn 82, Issue 2, 2012, Pages 103-115

  Bidard, F C ^a   Ferrand, F R ^b   Huguet, F ^c   Hammel, P ^d   Louvet, C ^e   Malka, D ^f   Boige, V ^f   Ducreux, M ^f   Andre, T ^g   de Gramont, A ^g   Mariani, P ^a   Pierga, J Y ^a,h  

^a INSTITUT CURIE   (France)

^b University of Paris Descartes   (France)

^c HÔPITAL TENON   (France)

^d BEAUJON HOSPITAL   (France)

^e INSTITUT MUTUALISTE MONTSOURIS   (France)

^f INSTITUT GUSTAVE ROUSSY   (France)

^g HÔPITAL SAINT ANTOINE   (France)

^h UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Biomarker; Circulating tumor cells; Disseminated tumor cells; Gastrointestinal cancer; Micrometastasis

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; BEVACIZUMAB; CARCINOEMBRYONIC ANTIGEN; CETUXIMAB; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 20; EDRECOLOMAB; EPITHELIAL CELL ADHESION MOLECULE; MESSENGER RNA; MUCIN 1; SURVIVIN; TELOMERASE REVERSE TRANSCRIPTASE; VASCULOTROPIN RECEPTOR 1;

ADJUVANT THERAPY; ADVANCED CANCER; BONE MARROW; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL ISOLATION; CELL SELECTION; CIRCULATING TUMOR CELL; COLON CANCER; COLORECTAL CANCER; COLORECTAL CARCINOMA; DIGESTIVE SYSTEM CANCER; GOLD STANDARD; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER METASTASIS; MAGNETIC SEPARATION; METASTASIS; NEUROENDOCRINE TUMOR; OVERALL SURVIVAL; PANCREAS CANCER; PANCREAS CARCINOMA; PORTAL VEIN; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; REVIEW; STOMACH ADENOCARCINOMA; TUMOR CELL;

GASTROINTESTINAL NEOPLASMS; HUMANS; NEOPLASTIC CELLS, CIRCULATING;

EID: 84859420898     PISSN: 10408428     EISSN: 18790461     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2011.05.008     Document Type: Review

References (147)

1. Paget S. The distribution of secondary growths in cancer of the breast 1889. Cancer Metastasis Rev 1989, 8(2):98-101.
2. Kim M.Y., Oskarsson T., Acharyya S., et al. Tumor self-seeding by circulating cancer cells. Cell 2009, 139(7):1315-1326.
3. Bidard F.C., Kirova Y.M., Vincent-Salomon A., et al. Disseminated tumor cells and the risk of locoregional recurrence in nonmetastatic breast cancer. Ann Oncol 2009, 20(11):1836-1841.
4. Ashworth T.R. A case of cancer in which cells similar to those in the tumours were seen in blood after death. Aus Med J 1869, 14:146-149.
5. Pantel K., Alix-Panabieres C., Riethdorf S. Cancer micrometastases. Nat Rev Clin Oncol 2009, 6(6):339-351.
6. Rahbari N.N., Aigner M., Thorlund K., et al. Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Gastroenterology 2010, 138(5):1714-1726.
7. Muller V., Alix-Panabieres C., Pantel K. Insights into minimal residual disease in cancer patients: implications for anti-cancer therapies. Eur J Cancer 2010, 46(7):1189-1197.
8. Antolovic D., Galindo L., Carstens A., et al. Heterogeneous detection of circulating tumor cells in patients with colorectal cancer by immunomagnetic enrichment using different EpCAM-specific antibodies. BMC Biotechnol 2010, 10:35.
9. Chechlinska M., Kowalewska M., Nowak R. Systemic inflammation as a confounding factor in cancer biomarker discovery and validation. Nat Rev Cancer 2010, 10(1):2-3.
10. Allard W.J., Matera J., Miller M.C., et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 2004, 10(20):6897-6904.
11. Marrinucci D., Bethel K., Lazar D., et al. Cytomorphology of circulating colorectal tumor cells: a small case series. J Oncol 2010, 2010:861341.
12. Fehm T., Braun S., Muller V., et al. A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation. Cancer 2006, 107(5):885-892.
13. Riethdorf S., Fritsche H., Muller V., et al. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res 2007, 13(3):920-928.
14. Kraan J., Sleijfer S., Strijbos M.H., et al. External quality assurance of circulating tumor cell enumeration using the CellSearch((R)) system: a feasibility study. Cytometry B Clin Cytom 2011, 80(2):112-118.
15. Thorban S., Roder J.D., Nekarda H., Funk A., Siewert J.R., Pantel K. Immunocytochemical detection of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma. J Natl Cancer Inst 1996, 88(17):1222-1227.
16. Bonavina L., Soligo D., Quirici N., et al. Bone marrow-disseminated tumor cells in patients with carcinoma of the esophagus or cardia. Surgery 2001, 129(1):15-22.
17. Ryan P., McCarthy S., Kelly J., et al. Prevalence of bone marrow micrometastases in esophagogastric cancer patients with and without neoadjuvant chemoradiotherapy. J Surg Res 2004, 117(1):121-126.
18. Stoecklein N.H., Hosch S.B., Bezler M., et al. Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer. Cancer Cell 2008, 13(5):441-453.
19. Klein C.A. Parallel progression of primary tumours and metastases. Nat Rev Cancer 2009, 9(4):302-312.
20. Noh Y.H., Im G., Ku J.H., Lee Y.S., Ahn M.J. Detection of tumor cell contamination in peripheral blood by RT-PCR in gastrointestinal cancer patients. J Korean Med Sci 1999, 14(6):623-628.
21. Nakashima S., Natsugoe S., Matsumoto M., et al. Clinical significance of circulating tumor cells in blood by molecular detection and tumor markers in esophageal cancer. Surgery 2003, 133(2):162-169.
22. Liu Z., Jiang M., Zhao J., Ju H. Circulating tumor cells in perioperative esophageal cancer patients: quantitative assay system and potential clinical utility. Clin Cancer Res 2007, 13(10):2992-2997.
23. Setoyama T., Natsugoe S., Okumura H., Matsumoto M., Uchikado Y., Aikou T. Isolated tumour cells in blood and E-cadherin expression in oesophageal squamous cell cancer. Br J Surg 2007, 94(8):984-991.
24. Hashimoto T., Kajiyama Y., Tsutsumi-Ishii Y., Nagaoka I., Tsurumaru M. Circulating micrometastases of esophageal cancer detected by carcinoembryonic antigen mRNA reverse transcriptase-polymerase chain reaction: clinical implications. Dis Esophagus 2008, 21(8):690-696.
25. Huang P., Wang J., Guo Y., Xie W. Molecular detection of disseminated tumor cells in the peripheral blood in patients with gastrointestinal cancer. J Cancer Res Clin Oncol 2003, 129(3):192-198.
26. Ito H., Kanda T., Nishimaki T., Sato H., Nakagawa S., Hatakeyama K. Detection and quantification of circulating tumor cells in patients with esophageal cancer by real-time polymerase chain reaction. J Exp Clin Cancer Res 2004, 23(3):455-464.
27. Kaganoi J., Shimada Y., Kano M., Okumura T., Watanabe G., Imamura M. Detection of circulating oesophageal squamous cancer cells in peripheral blood and its impact on prognosis. Br J Surg 2004, 91(8):1055-1060.
28. Koike M., Hibi K., Kasai Y., Ito K., Akiyama S., Nakao A. Molecular detection of circulating esophageal squamous cell cancer cells in the peripheral blood. Clin Cancer Res 2002, 8(9):2879-2882.
29. Hoffmann A.C., Vallbohmer D., Grimminger P., et al. Preoperative survivin mRNA detection in peripheral blood is an independent predictor of outcome in esophageal carcinoma. Pharmacogenomics 2010, 11(3):341-347.
30. Cao M., Yie S.M., Wu S.M., et al. Detection of survivin-expressing circulating cancer cells in the peripheral blood of patients with esophageal squamous cell carcinoma and its clinical significance. Clin Exp Metastasis 2009, 26(7):751-758.
31. Nakamura T., Yasumura T., Hayashi K., et al. Immunocytochemical detection of circulating esophageal carcinoma cells by immunomagnetic separation. Anticancer Res 2000, 20(6C):4739-4744.
32. Hiraiwa K., Takeuchi H., Hasegawa H., et al. Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers. Ann Surg Oncol 2008, 15(11):3092-3100.
33. Schlimok G., Funke I., Pantel K., et al. Micrometastatic tumour cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significance. Eur J Cancer 1991, 27(11):1461-1465.
34. Jauch K.W., Heiss M.M., Gruetzner U., et al. Prognostic significance of bone marrow micrometastases in patients with gastric cancer. J Clin Oncol 1996, 14(6):1810-1817.
35. Macadam R., Sarela A., Wilson J., MacLennan K., Guillou P. Bone marrow micrometastases predict early post-operative recurrence following surgical resection of oesophageal and gastric carcinoma. Eur J Surg Oncol 2003, 29(5):450-454.
36. Oki E., Kakeji Y., Baba H., et al. Clinical significance of cytokeratin positive cells in bone marrow of gastric cancer patients. J Cancer Res Clin Oncol 2007, 133(12):995-1000.
37. Fujita Y., Terashima M., Hoshino Y., et al. Detection of cancer cells disseminated in bone marrow using real-time quantitative RT-PCR of CEA, CK19, and CK20 mRNA in patients with gastric cancer. Gastric Cancer 2006, 9(4):308-314.
38. Wang G.Y., Li Y., Yu Y.M., et al. Detection of disseminated tumor cells in bone marrow of gastric cancer using magnetic activated cell sorting and fluorescent activated cell sorting. J Gastroenterol Hepatol 2009, 24(2):299-306.
39. Dardaei L., Shahsavani R., Ghavamzadeh A., et al. The detection of disseminated tumor cells in bone marrow and peripheral blood of gastric cancer patients by multimarker (CEA, CK20, TFF1 and MUC2) quantitative real-time PCR. Clin Biochem 2011, 44(4):325-330.
40. Maehara Y., Hasuda S., Abe T., et al. Tumor angiogenesis and micrometastasis in bone marrow of patients with early gastric cancer. Clin Cancer Res 1998, 4(9):2129-2134.
41. Matsunami K., Nakamura T., Oguma H., Kitamura Y., Takasaki K. Detection of bone marrow micrometastasis in gastric cancer patients by immunomagnetic separation. Ann Surg Oncol 2003, 10(2):171-175.
42. Kakeji Y., Maehara Y., Shibahara K., et al. Clinical significance of micrometastasis in bone marrow of patients with gastric cancer and its relation to angiogenesis. Gastric Cancer 1999, 2(1):46-51.
43. Allgayer H., Heiss M.M., Riesenberg R., et al. Urokinase plasminogen activator receptor (uPA-R): one potential characteristic of metastatic phenotypes in minimal residual tumor disease. Cancer Res 1997, 57(7):1394-1399.
44. Heiss M.M., Allgayer H., Gruetzner K.U., Babic R., Jauch K.W., Schildberg F.W. Clinical value of extended biologic staging by bone marrow micrometastases and tumor-associated proteases in gastric cancer. Ann Surg 1997, 226(6):736-744. discussion 744-835.
45. Heiss M.M., Simon E.H., Beyer B.C., et al. Minimal residual disease in gastric cancer: evidence of an independent prognostic relevance of urokinase receptor expression by disseminated tumor cells in the bone marrow. J Clin Oncol 2002, 20(8):2005-2016.
46. Buergy D., Fuchs T., Kambakamba P., et al. Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancer. Cancer 2009, 115(20):4667-4678.
47. Wu C.H., Lin S.R., Hsieh J.S., et al. Molecular detection of disseminated tumor cells in the peripheral blood of patients with gastric cancer: evaluation of their prognostic significance. Dis Markers 2006, 22(3):103-109.
48. Yeh K.H., Chen Y.C., Yeh S.H., Chen C.P., Lin J.T., Cheng A.L. Detection of circulating cancer cells by nested reverse transcription-polymerase chain reaction of cytokeratin-19 (K19): possible clinical significance in advanced gastric cancer. Anticancer Res 1998, 18(2B):1283-1286.
49. Shin J.H., Chung J., Kim H.O., et al. Detection of cancer cells in peripheral blood of stomach cancer patients using RT-PCR amplification of tumour-specific mRNAs. Aliment Pharmacol Ther 2002, 16(Suppl. 2):137-144.
50. Shimizu F., Nakayama J., Ishizone S., et al. Usefulness of the real-time reverse transcription-polymerase chain reaction assay targeted to alpha1,4-N-acetylglucosaminyltransferase for the detection of gastric cancer. Lab Invest 2003, 83(2):187-197.
51. Szatanek R., Drabik G., Baran J., et al. Detection of isolated tumour cells in the blood and bone marrow of patients with gastric cancer by combined sorting, isolation and determination of MAGE-1, -2 mRNA expression. Oncol Rep 2008, 19(4):1055-1060.
52. Miyazono F., Natsugoe S., Takao S., et al. Surgical maneuvers enhance molecular detection of circulating tumor cells during gastric cancer surgery. Ann Surg 2001, 233(2):189-194.
53. Ikeguchi M., Kaibara N. Detection of circulating cancer cells after a gastrectomy for gastric cancer. Surg Today 2005, 35(6):436-441.
54. Obayashi T., Taniguchi H., Mugitani T., et al. Safety and utility of autologous blood transfusion for resection of metastatic liver tumor. Hepatogastroenterology 2001, 48(39):812-817.
55. Futamura N., Nakanishi H., Hirose H., Nakamura S., Tatematsu M. The effect of storage on the survival of cancer cells in blood and efficient elimination of contaminating cancer cells by a leukocyte depletion filter. Am Surg 2005, 71(7):585-590.
56. Kolodziejczyk P., Pituch-Noworolska A., Drabik G., et al. The effects of preoperative chemotherapy on isolated tumour cells in the blood and bone marrow of gastric cancer patients. Br J Cancer 2007, 97(5):589-592.
57. Kaplan R.N., Riba R.D., Zacharoulis S., et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005, 438(7069):820-827.
58. Mimori K., Fukagawa T., Kosaka Y., et al. Hematogenous metastasis in gastric cancer requires isolated tumor cells and expression of vascular endothelial growth factor receptor-1. Clin Cancer Res 2008, 14(9):2609-2616.
59. Matsusaka S., Chin K., Ogura M., et al. Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer. Cancer Sci 2010, 101(4):1067-1071.
60. Ko A.H., Scott J., Tempero M.A., Park J.W. Detection and significance of circulating tumor cells (CTC) in patients with metastatic pancreatic cancer (PC) receiving systemic therapy. J Clin Oncol 2007, 25(18S). Abstract 4596.
61. Kurihara T., Itoi T., Sofuni A., et al. Detection of circulating tumor cells in patients with pancreatic cancer: a preliminary result. J Hepatobiliary Pancreat Surg 2008, 15(2):189-195.
62. Negin B.P., Meropol N.J., Alpaugh R.K., et al. Characterization and prognostic significance of circulating tumor cells in the peripheral blood of patients with metastatic pancreatic cancer. J Clin Oncol 2010, 28(15s). abstract 4127.
63. Nagrath S., Sequist L.V., Maheswaran S., et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 2007, 450(7173):1235-1239.
64. Stott S.L., Lee R.J., Nagrath S., et al. Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer. Sci Transl Med 2010, 2(25). 25-23.
65. Z'Graggen K., Centeno B.A., Fernandez-del Castillo C., et al. Biological implications of tumor cells in blood and bone marrow of pancreatic cancer patients. Surgery 2001, 129(5):537-546.
66. Vogel I., Kruger U., Marxsen J., et al. Disseminated tumor cells in pancreatic cancer patients detected by immunocytology: a new prognostic factor. Clin Cancer Res 1999, 5(3):593-599.
67. Uchikura K., Takao S., Nakajo A., et al. Intraoperative molecular detection of circulating tumor cells by reverse transcription-polymerase chain reaction in patients with biliary-pancreatic cancer is associated with hematogenous metastasis. Ann Surg Oncol 2002, 9(4):364-370.
68. Soeth E., Grigoleit U., Moellmann B., et al. Detection of tumor cell dissemination in pancreatic ductal carcinoma patients by CK 20 RT-PCR indicates poor survival. J Cancer Res Clin Oncol 2005, 131(10):669-676.
69. Thorban S., Roder J.D., Siewert J.R. Detection of micrometastasis in bone marrow of pancreatic cancer patients. Ann Oncol 1999, 10(Suppl. 4):111-113.
70. Mudan S., Giakoustidis A., Thillainayagam A.V., Jacob J., Stebbing J. Clinical utility of circulating tumor cell measurement in the diagnosis of indeterminate lesions of the pancreas. Future Oncol 2010, 6(1):177-179.
71. Hoffmann K., Kerner C., Wilfert W., et al. Detection of disseminated pancreatic cells by amplification of cytokeratin-19 with quantitative RT-PCR in blood, bone marrow and peritoneal lavage of pancreatic carcinoma patients. World J Gastroenterol 2007, 13(2):257-263.
72. Ishizone S., Yamauchi K., Kawa S., et al. Clinical utility of quantitative RT-PCR targeted to alpha1,4-N-acetylglucosaminyltransferase mRNA for detection of pancreatic cancer. Cancer Sci 2006, 97(2):119-126.
73. Zhang Y.L., Feng J.G., Gou J.M., Zhou L.X., Wang P. Detection of CK20mRNA in peripheral blood of pancreatic cancer and its clinical significance. World J Gastroenterol 2005, 11(7):1023-1027.
74. Zhou J., Hu L., Yu Z., et al. Marker expression in circulating cancer cells of pancreatic cancer patients. J Surg Res 2010, ahead of print.
75. Khan M.S., Tsigani T., Rashid M., et al. Circulating tumor cells and EpCAM expression in neuroendocrine tumors. Clin Cancer Res 2011, 17(2):337-345.
76. Lindemann F., Schlimok G., Dirschedl P., Witte J., Riethmüller G. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 1992, 340(8821):685-689.
77. Braun S., Hepp F., Kentenich C.R., et al. Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow. Clin Cancer Res 1999, 5(12):3999-4004.
78. Hjelm Skog A., Ragnhammar P., Fagerberg J., et al. Clinical effects of monoclonal antibody 17-1A combined with granulocyte/macrophage-colony-stimulating factor and interleukin-2 for treatment of patients with advanced colorectal carcinoma. Cancer Immunol Immunother 1999, 48(8):463-470.
79. Punt C.J., Nagy A., Douillard J.Y., et al. Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study. Lancet 2002, 360(9334):671-677.
80. Fields A.L., Keller A., Schwartzberg L., et al. Adjuvant therapy with the monoclonal antibody edrecolomab plus fluorouracil-based therapy does not improve overall survival of patients with stage III colon cancer. J Clin Oncol 2009, 27(12):1941-1947.
81. Koch M., Kienle P., Logan E., et al. Detection of disseminated tumor cells in liver biopsies of colorectal cancer patients is not associated with a worse prognosis. Ann Surg Oncol 2007, 14(2):810-817.
82. Leather A.J., Gallegos N.C., Kocjan G., et al. Detection and enumeration of circulating tumour cells in colorectal cancer. Br J Surg 1993, 80(6):777-780.
83. Hayashi N., Egami H., Kai M., Kurusu Y., Takano S., Ogawa M. No-touch isolation technique reduces intraoperative shedding of tumor cells into the portal vein during resection of colorectal cancer. Surgery 1999, 125(4):369-374.
84. Sales J.P., Wind P., Douard R., Cugnenc P.H., Loric S. Blood dissemination of colonic epithelial cells during no-touch surgery for rectosigmoid cancer [letter]. Lancet 1999, 354(9176):392.
85. Yamaguchi K., Takagi Y., Aoki S., Futamura M., Saji S. Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg 2000, 232(1):58-65.
86. Maruthachalam K., Lash G.E., Shenton B.K., Horgan A.F. Tumour cell dissemination following endoscopic stent insertion. Br J Surg 2007, 94(9):1151-1154.
87. Patel H., Le Marer N., Wharton R.Q., et al. Clearance of circulating tumor cells after excision of primary colorectal cancer. Ann Surg 2002, 235(2):226-231.
88. Kienle P., Koch M., Autschbach F., et al. Decreased detection rate of disseminated tumor cells of rectal cancer patients after preoperative chemoradiation: a first step towards a molecular surrogate marker for neoadjuvant treatment in colorectal cancer. Ann Surg 2003, 238(3):324-330. discussion 330-1.
89. Koch M., Weitz J., Kienle P., et al. Comparative analysis of tumor cell dissemination in mesenteric, central, and peripheral venous blood in patients with colorectal cancer. Arch Surg 2001, 136(1):85-89.
90. Thorsteinsson M., Soletormos G., Jess P. Low number of detectable circulating tumor cells in non-metastatic colon cancer. Anticancer Res 2011, 31(2):613-617.
91. Bessa X., Elizalde J.I., Boix L., et al. Lack of prognostic influence of circulating tumor cells in peripheral blood of patients with colorectal cancer. Gastroenterology 2001, 120(5):1084-1092.
92. Katsuno H., Zacharakis E., Aziz O., et al. Does the presence of circulating tumor cells in the venous drainage of curative colorectal cancer resections determine prognosis? A meta-analysis. Ann Surg Oncol 2008, 15(11):3083-3091.
93. Uen Y.H., Lin S.R., Wu D.C., et al. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection. Ann Surg 2007, 246(6):1040-1046.
94. Vlems F.A., Diepstra J.H., Punt C.J., et al. Detection of disseminated tumour cells in blood and bone marrow samples of patients undergoing hepatic resection for metastasis of colorectal cancer. Br J Surg 2003, 90(8):989-995.
95. Vogelaar F.J., Mesker W.E., Rijken A.M., et al. Clinical impact of different detection methods for disseminated tumor cells in bone marrow of patients undergoing surgical resection of colorectal liver metastases: a prospective follow-up study. BMC Cancer 2010, 10:153.
96. Bidard F.C., Vincent-Salomon A., Sigal-Zafrani B., et al. Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells. Ann Oncol 2008, 19:496-500.
97. Nakamori S., Kameyama M., Furukawa H., et al. Genetic detection of colorectal cancer cells in circulation and lymph nodes. Dis Colon Rectum 1997, 40(10 Suppl.):S29-36.
98. Thebo J.S., Senagore A.J., Krygier S., Luchtefeld M.A. K-ras mutational analysis of polyclonal colorectal cancers identifies uniclonal circulating tumor cells. Am Surg 2001, 67(8):802-805.
99. Iinuma H., Okinaga K., Adachi M., et al. Detection of tumor cells in blood using CD45 magnetic cell separation followed by nested mutant allele-specific amplification of p53 and K-ras genes in patients with colorectal cancer. Int J Cancer 2000, 89(4):337-344.
100. Khan Z.A., Jonas S.K., Le-Marer N., et al. P53 mutations in primary and metastatic tumors and circulating tumor cells from colorectal carcinoma patients. Clin Cancer Res 2000, 6(9):3499-3504.
101. Topal B., Aerts J.L., Roskams T., et al. Cancer cell dissemination during curative surgery for colorectal liver metastases. Eur J Surg Oncol 2005, 31(5):506-511.
102. Jiao L.R., Apostolopoulos C., Jacob J., et al. Unique localization of circulating tumor cells in patients with hepatic metastases. J Clin Oncol 2009, 27(36):6160-6165.
103. Schmidt T., Koch M., Antolovic D., et al. Influence of two different resection techniques (conventional liver resection versus anterior approach) of liver metastases from colorectal cancer on hematogenous tumor cell dissemination - prospective randomized multicenter trial. BMC Surg 2008, 8:6.
104. Aquino A., Prete S.P., Balduzzi A., et al. A novel method for monitoring response to chemotherapy based on the detection of circulating cancer cells: a case report. J Chemother 2002, 14(4):412-416.
105. Cohen S.J., Punt C.J., Iannotti N., et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 2008, 26(19):3213-3221.
106. Tol J., Koopman M., Miller M.C., et al. Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents. Ann Oncol 2010, 21(5):1006-1012.
107. Bidard F.C., Mathiot C., Degeorges A., et al. Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy. Ann Oncol 2010, 21(9):1765-1771.
108. Yamanaka N., Okamoto E., Fujihara S., et al. Do the tumor cells of hepatocellular carcinomas dislodge into the portal venous stream during hepatic resection?. Cancer 1992, 70(9):2263-2267.
109. Komeda T., Fukuda Y., Sando T., et al. Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood. Cancer 1995, 75(9):2214-2219.
110. Matsumura M., Niwa Y., Kato N., et al. Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma. Hepatology 1994, 20(6):1418-1425.
111. Aselmann H., Wolfes H., Rohde F., et al. Quantification of alpha 1-fetoprotein mRNA in peripheral blood and bone marrow: a tool for perioperative evaluation of patients with hepatocellular carcinoma. Langenbecks Arch Surg 2001, 386(2):118-123.
112. Cillo U., Navaglia F., Vitale A., et al. Clinical significance of alpha-fetoprotein mRNA in blood of patients with hepatocellular carcinoma. Clin Chim Acta 2004, 347(1-2):129-138.
113. Kienle P., Weitz J., Klaes R., et al. Detection of isolated disseminated tumor cells in bone marrow and blood samples of patients with hepatocellular carcinoma. Arch Surg 2000, 135(2):213-218.
114. Leonhardt U., Ritzel U., Ottleben M., Vignoli A., Ramadori G Detection of circulating albumin-mRNA by RT-PCR does not indicate metastasizing hepatocellular carcinoma. Langenbecks Arch Chir 1997, 382(2):83-86.
115. Wong I.H., Lau W.Y., Leung T., Yeo W., Johnson P.J. Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis. Clin Cancer Res 1999, 5(12):4021-4027.
116. Waguri N., Suda T., Nomoto M., et al. Sensitive and specific detection of circulating cancer cells in patients with hepatocellular carcinoma; detection of human telomerase reverse transcriptase messenger RNA after immunomagnetic separation. Clin Cancer Res 2003, 9(8):3004-3011.
117. Yang S.Z., Dong J.H., Li K., Zhang Y., Zhu J. Detection of AFPmRNA and melanoma antigen gene-1mRNA as markers of disseminated hepatocellular carcinoma cells in blood. Hepatobiliary Pancreat Dis Int 2005, 4(2):227-233.
118. Vona G., Sabile A., Louha M., et al. Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulating tumor cells. Am J Pathol 2000, 156(1):57-63.
119. Vona G., Estepa L., Beroud C., et al. Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer. Hepatology 2004, 39(3):792-797.
120. Zee B.C., Wong, Kuhn T., et al. Detection of circulating tumor cells (CTCs) in patients with hepatocellular carcinoma (HCC). J Clin Oncol 2007, 25:15037.
121. Yang Z.F., Ngai P., Ho D.W., et al. Identification of local and circulating cancer stem cells in human liver cancer. Hepatology 2008, 47(3):919-928.
122. Buyse M., Sargent D.J., Grothey A., Matheson A., de Gramont A. Biomarkers and surrogate end points - the challenge of statistical validation. Nat Rev Clin Oncol 2010, 7(6):309-317.
123. Soeth E., Vogel I., Rd C., et al. Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. Cancer Res 1997, 57(15):3106-3110.
124. Nishida S., Kitamura K., Ichikawa D., Koike H., Tani N., Yamagishi H. Molecular detection of disseminated cancer cells in the peripheral blood of patients with gastric cancer. Anticancer Res 2000, 20(3B):2155-2159.
125. Majima T., Ichikura T., Takayama E., Chochi K., Mochizuki H. Detecting circulating cancer cells using reverse transcriptase-polymerase chain reaction for cytokeratin mRNA in peripheral blood from patients with gastric cancer. Jpn J Clin Oncol 2000, 30(11):499-503.
126. Sumikura S., Ishigami S., Natsugoe S., et al. Disseminated cancer cells in the blood and expression of sialylated antigen in gastric cancer. Cancer Lett 2003, 200(1):77-83.
127. Seo J.H., Choi C.W., Kim B.S., et al. Follow-up study of peripheral blood carcinoembryonic antigen mRNA using reverse transcription-polymerase chain reaction as an early marker of clinical recurrence in patients with curatively resected gastric cancer. Am J Clin Oncol 2005, 28(1):24-29.
128. Illert B., Fein M., Otto C., et al. Disseminated tumor cells in the blood of patients with gastric cancer are an independent predictive marker of poor prognosis. Scand J Gastroenterol 2005, 40(7):843-849.
129. Uen Y.H., Lin S.R., Wu C.H., et al. Clinical significance of MUC1 and c-Met RT-PCR detection of circulating tumor cells in patients with gastric carcinoma. Clin Chim Acta 2006, 367(1-2):55-61.
130. Wu C.H., Lin S.R., Yu F.J., et al. Development of a high-throughput membrane-array method for molecular diagnosis of circulating tumor cells in patients with gastric cancers. Int J Cancer 2006, 119(2):373-379.
131. Koga T., Tokunaga E., Sumiyoshi Y., et al. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR. Hepatogastroenterology 2008, 55(84):1131-1135.
132. Yie S.M., Lou B., Ye S.R., et al. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse. Ann Surg Oncol 2008, 15(11):3073-3082.
133. Saad A.A., Awed N.M., Abd Elkerim N.N., et al. Prognostic significance of E-cadherin expression and peripheral blood micrometastasis in gastric carcinoma patients. Ann Surg Oncol 2010, 17(11):3059-3067.
134. Cohen S.J., Alpaugh R.K., Gross S., et al. Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer. Clin Colorectal Cancer 2006, 6(2):125-132.
135. Sastre J., Maestro M.L., Puente J., et al. Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables. Ann Oncol 2008, 19(5):935-938.
136. Maestro L.M., Sastre J., Rafael S.B., et al. Circulating tumor cells in solid tumor in metastatic and localized stages. Anticancer Res 2009, 29(11):4839-4843.
137. Cohen S.J., Punt C.J., Iannotti N., et al. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann Oncol 2009, 20(7):1223-1229.
138. Papavasiliou P., Fisher T., Kuhn J., Nemunaitis J., Lamont J. Circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer. Proc (Bayl Univ Med Cent) 2010, 23(1):11-14.
139. Louha M., Poussin K., Ganne N., et al. Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer. Hepatology 1997, 26(4):998-1005.
140. Matsumura M., Shiratori Y., Niwa Y., et al. Presence of alpha-fetoprotein mRNA in blood correlates with outcome in patients with hepatocellular carcinoma. J Hepatol 1999, 31(2):332-339.
141. Wong I.H., Lau W.Y., Leung T., Johnson P.J. Quantitative comparison of alpha-fetoprotein and albumin mRNA levels in hepatocellular carcinoma/adenoma, non-tumor liver and blood: implications in cancer detection and monitoring. Cancer Lett 2000, 156(2):141-149.
142. Miyamoto A., Nagano H., Sakon M., et al. Clinical application of quantitative analysis for detection of hematogenous spread of hepatocellular carcinoma by real-time PCR. Int J Oncol 2001, 18(3):527-532.
143. Witzigmann H., Geissler F., Benedix F., et al. Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma. Surgery 2002, 131(1):34-43.
144. Gross-Goupil M., Saffroy R., Azoulay D., et al. Real-time quantification of AFP mRNA to assess hematogenous dissemination after transarterial chemoembolization of hepatocellular carcinoma. Ann Surg 2003, 238(2):241-248.
145. Jeng K.S., Sheen I.S., Tsai Y.C. Circulating messenger RNA of alpha-fetoprotein: a possible risk factor of recurrence after resection of hepatocellular carcinoma. Arch Surg 2004, 139(10):1055-1060.
146. Jeng K.S., Sheen I.S., Tsai Y.C. Does the presence of circulating hepatocellular carcinoma cells indicate a risk of recurrence after resection?. Am J Gastroenterol 2004, 99(8):1503-1509.
147. Morimoto O., Nagano H., Miyamoto A., et al. Association between recurrence of hepatocellular carcinoma and alpha-fetoprotein messenger RNA levels in peripheral blood. Surg Today 2005, 35(12):1033-1041.